The Maternal Pertussis Study: best practice for the communication of pertussis (whooping cough) booster vaccine recommendations to new mothers.
Active, not recruiting
- Conditions
- pertussisReproductive Health and Childbirth - Childbirth and postnatal carePublic Health - Health promotion/educationInfection - Other infectious diseases
- Registration Number
- ACTRN12613000893707
- Lead Sponsor
- Associate Professor John Sinn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Female
- Target Recruitment
- 1080
Inclusion Criteria
Postpartum women not up to date with pertussis booster recommendations ( dTpa <10 years)
Exclusion Criteria
Requires an interpreter.
Unable to given written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pertussis booster vaccine uptake by postpartum women, assessed by follow up questionnaire completed prior to discharge.[Immediate postpartum period (prior to discharge from hospital following childbirth). ]
- Secondary Outcome Measures
Name Time Method Baseline attitude and other factors influencing vaccine uptake were assessed using a self-administered, paper-based questionnaire completed at the participant's bedside. <br><br>The questionnaire was comprised of 5 parts structure according to the Health Belief Model framework, with questions on: a) pertussis vaccination information sources b) pertussis susceptibility and severity c) vaccine benefits and barriers d) intentions to be vaccinated and e) demographic information. [At baseline (following completion of the baseline questionnaire, prior to allocation of the intervention or control). ];Additional follow up ( by preferred method of phone or email) to assess household pertussis vaccine status and household exposure to pertussis and/or epidsode/s of pertussis. [from six months postpartum]